Comparison Neogenomics (NEO) with Competitors
Neogenomics (NEO) industry is Diagnostics & Research.
Profit Margin
NEO-5.20%
Industry7.80%
Upside-13.00%
Operating Margin
NEO-7.05%
Industry4.14%
Upside-11.19%
Debt-to-Equity
NEO40.86%
Industry-155.44%
Upside+196.31%
Free Cash Flow Yield
NEO-8.64%
Industry3.19%
Upside-11.83%
P/E
NEO-2.34
Industry48.84
Upside-5117.91%
Forward P/E
NEO222.22
Industry23.26
Upside+855.52%
P/S
NEO1.73
Industry4.50
Upside-61.46%
P/B
NEO1.34
Industry3.98
Upside-66.35%